Ollie's Bargain Outlet (OLLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dollar General (DG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tesla's sales in Europe plunged in April as the electric car maker faced backlash over Elon Musk's political work and rising competition from China-based rival BYD.

“We are in the middle of a tectonic shift in the adoption of our software, particularly in the U.S.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=150356&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Digimarc Corporation ("Digimarc" or the "Company") (NASDAQ:DMRC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

DUBLIN, May 27, 2025 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced that it has executed non-binding Heads of Terms (“Heads of Terms”) with a privately-held United Kingdom-based fuel distribution business (“Target”) to acquire 100% of the equity of Target and certain related companies from their existing shareholders. The signing of the Heads of Terms follows the signing of a non-binding Letter of Intent between the parties, which was previously announced by the Company on April 9, 2025.

RESTON, Va., May 27, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, has been added as a member of the broad-market Russell 3000® Index and the small-cap Russell 2000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution.

Two new products deliver critical voltage and temperature monitoring systems Two new products deliver critical voltage and temperature monitoring systems

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your UnitedHealth Group Incorporated (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unitedhealth-group-incorporated-lawsuit-submission-form?prid=150367&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150363&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=150360&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ:IOVA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=150361&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=150364&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

CALGARY, AB , May 27, 2025 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) Executive Vice-President and Chief Financial Officer Nadeem Velani and Executive Vice-President and Chief Operating Officer Mark Redd will address the 2025 Wells Fargo Industrials & Materials Securities Conference on June 10, 2025, at 8:00 a.m. CT. CPKC will provide access to the live audio webcast at investor.cpkcr.com.

Cosan S.A. offers diversified exposure to strategic sectors in Brazil, with unique assets and strong synergies among its holdings, especially Raízen and Rumo. The company trades at attractive valuations, with significant upside potential if interest rates fall and subsidiaries' performance improves. Cosan faces challenges from high debt and Brazil's elevated interest rates, which strain cash flow and limit dividend potential.

We rate DocuSign a buy with a $130 PT, driven by faster-than-expected revenue growth and accelerating Intelligent Agreement Management monetization. IAM is rapidly scaling, now >20% of new direct deals, and is set to drive both top-line growth and margin expansion beyond consensus expectations. Cloud migration is structurally expanding margins, supporting mid-30% operating margins and enabling reinvestment for sustainable, profitable scale.